The Role of Inhibition of Apoptosis in Acute Leukemias and Myelodysplastic Syndrome
Avoidance of apoptosis is a key mechanism that malignancies, including acute leukemias and MDS, utilize in order to proliferate and resist chemotherapy. Recently, venetoclax, an inhibitor of the anti-apoptotic protein BCL-2, has been approved for the treatment of upfront AML in an unfit, elderly pop...
Main Authors: | Amanda McBride, Sarah Houtmann, Lindsay Wilde, Carlos Vigil, Christine M. Eischen, Margaret Kasner, Neil Palmisiano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00192/full |
Similar Items
-
Acute leukemia / myelodysplastic syndrome as a sequelae of carcinoma breast: A report of five cases from north India
by: Bhatia Prateek, et al.
Published: (2009-04-01) -
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
by: Jing-dong Zhou, et al.
Published: (2019-06-01) -
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
by: Shirin Hafezi, et al.
Published: (2021-03-01) -
Genetic Models of Leukemia in Zebrafish
by: Jeremy T. Baeten, et al.
Published: (2018-09-01) -
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
by: Yunxiong Wei, et al.
Published: (2020-11-01)